MML Investors Services LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 23.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,706 shares of the company's stock after selling 4,110 shares during the quarter. MML Investors Services LLC's holdings in HCA Healthcare were worth $4,114,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently modified their holdings of HCA. Barclays PLC increased its holdings in HCA Healthcare by 22.3% during the third quarter. Barclays PLC now owns 571,975 shares of the company's stock worth $232,467,000 after buying an additional 104,409 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $688,000. Franklin Resources Inc. increased its position in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company's stock worth $660,842,000 after buying an additional 174,946 shares during the last quarter. American Trust purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at $372,000. Finally, Oddo BHF Asset Management Sas bought a new stake in HCA Healthcare in the 3rd quarter valued at about $3,278,000. Hedge funds and other institutional investors own 62.73% of the company's stock.
Insider Activity at HCA Healthcare
In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.30% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on HCA shares. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays lowered their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 27th. Cantor Fitzgerald restated an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $381.13.
Check Out Our Latest Analysis on HCA
HCA Healthcare Trading Up 0.0 %
Shares of HCA stock traded up $0.09 during trading hours on Thursday, reaching $345.17. 291,271 shares of the stock were exchanged, compared to its average volume of 1,393,391. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $84.98 billion, a price-to-earnings ratio of 15.75, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company's 50-day moving average price is $331.02 and its 200-day moving average price is $331.49.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business's revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.36 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is presently 12.81%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.